Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice
Author:
Affiliation:
1. Department of Pharmacy, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
2. Parexel China Co., Ltd., Chengdu 610000, China
Publisher
The Korean Physiological Society and The Korean Society of Pharmacology
Subject
Pharmacology,Physiology
Link
http://pdf.medrang.co.kr/KJPP2/2023/027/KJPP027-03-221.pdf
Reference30 articles.
1. The Global Epidemiology of Diabetes and Kidney Disease
2. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: Estimates from Global Burden of Disease 2017
3. Changes in Diabetes-Related Complications in the United States
4. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
5. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential Effects of Traditional Chinese Medicine in Anti-Aging and Aging-Related Diseases: Current Evidence and Perspectives;Clinical Interventions in Aging;2024-05
2. Puerarin: A Potential Supplement for Diabetes and its Complications;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-03-06
3. Diphenyl Diselenide Protects Against Diabetic Nephropathy Through Modulating Oxidative Stress and Gut Microbiota Dysbiosis in Streptozotocin-Induced Diabetic Rats;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3